Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
p acnes corneal ulcer endopthalmitis kaposi esotropia intraocular uveitis optic neuritis anisocoria retinitisYour Article Summary
The eye in cerebral malaria: what can it teach us
Transactions of the Royal Society of Tropical Medicine and Hygiene, 06/25/09
Maude RJ et al. - The central mechanism causing malarial retinopathy appears to be microvascular obstruction, which has been demonstrated in affected retinas by fluorescein angiography. The presence in a central nervous system tissue of microvascular obstruction strongly supports the hypothesis that the sequestration of erythrocytes in small blood vessels and consequent obstruction of microcirculatory flow is an important mechanism causing coma and death in CM. Despite advances in the antimalarial treatment of severe malaria, its mortality remains approximately 15–20%. Adjunctive treatment targeting sequestration is a promising strategy to further lower mortality.
Today in Neuro-Ophthalmology...keeping you current
Receive free subspecialty "5-minute updates" via email
Headache and the eye
Current Opinion in Ophthalmology, 10/19/09
Topical cyclosporine A for the dry eye findings of thyroid orbitopathy patients
Eye, 10/20/09
Neuromyelitis optica: current concepts and prospects for future management
Current Opinion in Ophthalmology, 10/16/09
Today in Ophthalmic Infections...keeping you current
Receive free subspecialty "5-minute updates" via email
Practice Patterns in the Management of Fungal Corneal Ulcers
Cornea, 10/09/09
Posterior Uveitis Secondary to Syphilis
Clinical Medicine & Research, 10/09/09
Subconjunctival Mycetoma After Sub-Tenon's Corticosteroid Injection
Cornea, 10/15/09
Today in Retina...keeping you current
Receive free subspecialty "5-minute updates" via email
Five-year Results of a Randomized Trial with Open-label Extension of Triamcinolone Acetonide for Refractory Diabetic Macular Edema
Ophthalmology, 10/05/09
Bevacizumab vs Ranibizumab for Age-related Macular Degeneration: Early Results of a Prospective Double-Masked, Randomized Clinical Trial
American Journal of Ophthalmology, 10/07/09
Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion
Eye, 10/06/09
Article Search
Sponsor


See Latest Articles


